hotspot -WSS

hotspot

author：focus 2025-09-27 07:51:23 - browse：195

Anna Yeo/STAT

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case?

In utero gene editing, or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby preventing that entire protocol and the onset of symptoms in the first place. It would also challenge the need for the ethically fraught enterprise of embryo editing, as the treatment would only make edits in the DNA of the individual fetus — edits which would not be passed on in a heritable way.

Watch this video to learn more about in utero gene editing, how it works, and why scientists believe it might be an advantageous approach to treating certain genetic diseases.

Previous article： Sports medicine is finally prioritizing gender equality
Next article： International team creates first chimeric human

WSS

Covid isolation guidance eased by the CDC

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Headspace, Meta partner to launch VR meditation app for Quest

ALS groups 'won't be played again' by the FDA, drug sponsors

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

UnitedHealth quietly bought dozens of outpatient centers

Wikipedia

hotspot

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

Kenai launches with $82 million for Parkinson’s stem cell therapy

23andMe had bad news about my health. I wish a person had delivered it

CDC marks new Covid

Guidelines to prevent youth baseball injuries need more muscle

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Air quality improving but still lags in Black, Hispanic communities

entertainment

International team creates first chimeric human

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

NEJM study link tiny plastics in blood vessels to heart problems

RSV shot was 90% effective at preventing hospitalizations in kids

Former medical device CEO who sold dummy, plastic parts convicted of fraud

How to fix the rural physician shortage in the U.S.

focus

entertainment

knowledge

explore